A carregar...
Efficacy and Economic Value of Adjuvant Imatinib for Gastrointestinal Stromal Tumors
OBJECTIVE. This article presents the clinical effectiveness and cost-effectiveness of the use of adjuvant imatinib mesylate for treating patients with localized primary gastrointestinal stromal tumors (GISTs) and discusses the impact of prolonged treatment with adjuvant imatinib on health care costs...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4063396/ https://ncbi.nlm.nih.gov/pubmed/23709752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0474 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|